Core Laboratories enable discoveries to expand prediction, diagnosis and treatment of disease.
Clinicians apply genetic and genomic knowledge directly to care for patients.
LMM bridges research and clinical medicine, translating novel discoveries into genetic tests and accelerating personalized medicine by using new molecular tests in patient care.
The eighth annual conference will take place November 28-29, 2012 and will highlight the advances and international impact of personalized medicine.
The program is intended to advance translational genomics by leveraging the Partners Biorepository and RPDR to identify biological markers that can be used as potential predictive tests.